HK1220720A1 - 疫苗及其使用方法 - Google Patents
疫苗及其使用方法Info
- Publication number
- HK1220720A1 HK1220720A1 HK16108634.7A HK16108634A HK1220720A1 HK 1220720 A1 HK1220720 A1 HK 1220720A1 HK 16108634 A HK16108634 A HK 16108634A HK 1220720 A1 HK1220720 A1 HK 1220720A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- idna
- methods
- same
- vaccines
- idna vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/193—Equine encephalomyelitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36161—Methods of inactivation or attenuation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8148208P | 2008-07-17 | 2008-07-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1220720A1 true HK1220720A1 (zh) | 2017-05-12 |
Family
ID=41550920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16108634.7A HK1220720A1 (zh) | 2008-07-17 | 2016-07-20 | 疫苗及其使用方法 |
Country Status (7)
Country | Link |
---|---|
US (3) | US8691563B2 (zh) |
EP (3) | EP2977457B1 (zh) |
BR (1) | BRPI0916186B8 (zh) |
DK (2) | DK2310510T3 (zh) |
ES (2) | ES2544702T3 (zh) |
HK (1) | HK1220720A1 (zh) |
WO (1) | WO2010008576A2 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2544702T3 (es) | 2008-07-17 | 2015-09-02 | Medigen, Inc. | Vacunas en forma de ADNi y métodos para utilizarlas |
US10602508B2 (en) * | 2015-08-10 | 2020-03-24 | Qualcomm Incorporated | LTE-direct communication for vehicle-to-vehicle |
JP2020518648A (ja) | 2017-05-08 | 2020-06-25 | グリットストーン オンコロジー インコーポレイテッド | アルファウイルス新生抗原ベクター |
WO2019136309A1 (en) | 2018-01-04 | 2019-07-11 | Iconic Therapeutics, Inc. | Anti-tissue factor antibodies, antibody-drug conjugates, and related methods |
WO2020243719A1 (en) | 2019-05-30 | 2020-12-03 | Gritstone Oncology, Inc. | Modified adenoviruses |
AU2021320896A1 (en) | 2020-08-06 | 2023-03-23 | Gritstone Bio, Inc. | Multiepitope vaccine cassettes |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI9701774B8 (pt) * | 1997-04-11 | 2015-09-29 | Fundação Oswaldo Cruz Fiocruz | cdna mutante e infeccioso do vírus da febre amarela, constructo de dna, vírus recombinante de febre amarela e vacina para humanos contra infecções de febre amarela. |
WO1999050292A1 (en) * | 1998-03-27 | 1999-10-07 | The Secretary Of State For Defence | Recombinant virus |
FR2779736B1 (fr) * | 1998-06-12 | 2002-12-13 | Goemar Lab Sa | Genes codant pour des beta-agarases et leur utilisation pour la production d'enzymes de biodegradation des agars |
EP1137759A2 (en) * | 1998-12-07 | 2001-10-04 | U.S. Medical Research Institute of Infectious Diseases | Live attenuated venezuelan equine encephalitis vaccine |
GB2372991B (en) * | 2001-03-09 | 2004-11-17 | Fiocruz Fundacao Oswaldo Cruz | Flavivirus expression vector |
EP1399183B1 (en) * | 2001-05-31 | 2010-06-30 | Novartis Vaccines and Diagnostics, Inc. | Chimeric alphavirus replicon particles |
AU2003902842A0 (en) * | 2003-06-06 | 2003-06-26 | The University Of Queensland | Flavivirus replicon packaging system |
WO2005026316A2 (en) * | 2003-09-15 | 2005-03-24 | Bioption Ab | Alphavirus vaccines |
US7459163B2 (en) | 2004-02-25 | 2008-12-02 | University Of Kansas | Infectious DNA as a vaccine against west nile and other flaviviruses |
US20060198854A1 (en) | 2004-12-28 | 2006-09-07 | Peter Pushko | Vector platforms derived from the alphavirus vaccines |
ES2544702T3 (es) * | 2008-07-17 | 2015-09-02 | Medigen, Inc. | Vacunas en forma de ADNi y métodos para utilizarlas |
WO2011082388A2 (en) * | 2009-12-31 | 2011-07-07 | Medigen, Inc . | Infectious dna vaccines against chikungunya virus |
-
2009
- 2009-07-17 ES ES09798313.4T patent/ES2544702T3/es active Active
- 2009-07-17 EP EP15166439.8A patent/EP2977457B1/en active Active
- 2009-07-17 DK DK09798313.4T patent/DK2310510T3/en active
- 2009-07-17 WO PCT/US2009/004133 patent/WO2010008576A2/en active Application Filing
- 2009-07-17 ES ES15166439T patent/ES2902787T3/es active Active
- 2009-07-17 EP EP21192928.6A patent/EP3992296A1/en active Pending
- 2009-07-17 EP EP09798313.4A patent/EP2310510B1/en active Active
- 2009-07-17 DK DK15166439.8T patent/DK2977457T3/da active
- 2009-07-17 US US13/054,372 patent/US8691563B2/en active Active - Reinstated
- 2009-07-17 BR BRPI0916186A patent/BRPI0916186B8/pt active IP Right Grant
-
2014
- 2014-01-30 US US14/168,788 patent/US9968672B2/en active Active
-
2016
- 2016-07-20 HK HK16108634.7A patent/HK1220720A1/zh unknown
-
2018
- 2018-04-19 US US15/957,550 patent/US10653769B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20180243404A1 (en) | 2018-08-30 |
EP2310510B1 (en) | 2015-05-06 |
US9968672B2 (en) | 2018-05-15 |
BRPI0916186A2 (pt) | 2018-05-29 |
EP2310510A2 (en) | 2011-04-20 |
US10653769B2 (en) | 2020-05-19 |
EP2310510A4 (en) | 2012-01-25 |
ES2902787T3 (es) | 2022-03-29 |
DK2977457T3 (da) | 2021-12-06 |
EP3992296A1 (en) | 2022-05-04 |
US20110243989A1 (en) | 2011-10-06 |
ES2544702T3 (es) | 2015-09-02 |
US20140178430A1 (en) | 2014-06-26 |
BRPI0916186B8 (pt) | 2021-05-25 |
DK2310510T3 (en) | 2015-08-03 |
EP2977457A2 (en) | 2016-01-27 |
WO2010008576A3 (en) | 2010-04-29 |
BRPI0916186B1 (pt) | 2021-03-09 |
EP2977457B1 (en) | 2021-09-01 |
US8691563B2 (en) | 2014-04-08 |
WO2010008576A2 (en) | 2010-01-21 |
EP2977457A3 (en) | 2016-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1218427A1 (zh) | 改進的疫苗及其使用方法 | |
IL244197A0 (en) | Antibodies against cd100 and methods of using them | |
HK1209626A1 (zh) | 納米通道裝置和相關方法 | |
EP2352202A4 (en) | FUNCTIONAL DEVICE AND METHOD FOR MANUFACTURING THE SAME | |
IL287311A (en) | Antibodies and processes for their preparation | |
AU2013201592A1 (en) | Improved vaccines and methods for using the same | |
EP2308884A4 (en) | PROCESS FOR THE PREPARATION OF HETEROSUBSTITUTED ALKYLHALOHYDROSILANE AND ITS USE | |
EP2237857A4 (en) | REACTIVE COMPONENT REDUCTION SYSTEM AND METHODS OF USE | |
EP2113169A4 (en) | CLEANING DEVICE AND CLEANING METHOD FOR THE DEVICE | |
EP2307634A4 (en) | CLAMP AND USE METHOD FOR THE CLAMP | |
HK1220720A1 (zh) | 疫苗及其使用方法 | |
HK1163083A1 (zh) | 中間體和應用所述中間體製備恩替卡韋的方法 | |
EP2145715A4 (en) | WELDING DEVICE AND SETTING DEVICE FOR THE DEVICE | |
EP2307052A4 (en) | ANTI-BETA-2-MICROGLOBULIN AGENTS AND THEIR USE | |
ZA201001029B (en) | Vaccines | |
HK1212698A1 (zh) | 噻唑基和噁唑基異喹哪啶以及它們的使用方法 | |
IL201248A (en) | Polates are marked f 18 and methods for preparing them | |
EP2234731A4 (en) | ROTARY SPRAYER AND METHODS OF USING THE SAME | |
GB2465887B (en) | Projection device and projection method | |
EP2388320A4 (en) | ANTI-HS6ST2 ANTIBODIES AND USE THEREOF | |
GB0823333D0 (en) | Apparatus and methods | |
EP2248050A4 (en) | LOCATION DESCRIPTION FOR FEDERATION AND DISCOVERY ABILITY | |
IL213318A0 (en) | C1orf59 peptides and vaccines including the same | |
IL214453A0 (en) | Vangli peptides and vaccines including the same | |
GB0801326D0 (en) | Vaccines |